Author:
Zhao Liang,Li Na,Yang Harry
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Baxter L, Zhu H, Mackensen D, Butler W, Jain R (1995) Biodistribution of monoclonal antibodies: scale-up from mouse to human using a physiologically based pharmacokinetic model. Cancer Res 55:4611–4622
2. Beck BD, Mattuck RL, Bowers TS, Cohen JT, O’Flaherty E (2001) The development of a stochastic physiologically-based pharmacokinetic model for lead. Sci Total Environ 274:15–19
3. Cheng H, Gillespie WR (1996) Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding. J Pharmacokinet Pharmacodyn 24:389–402
4. Davda JP, Jain M, Batra SK, Gwilt PR, Robinson DH (2008) A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs. Int Immunopharmacol 8:401–413
5. Garg A, Balthasar JP (2007) Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. J Pharmacokinet Pharmacodyn 34:687–709
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献